Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-12-31FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Nephron Pharmaceuticals Corporation)
The FDA approved Nephron Pharmaceuticals' original application for a generic ipratropium bromide and albuterol sulfate combination inhaler f…
-
FDA approval · 2007-12-31FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic ipratropium bromide and albuterol sulfate inhalation product.
-
FDA approval · 2007-10-31FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide/formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP. The ac…
-
FDA approval · 2007-10-26FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate from AstraZeneca, updating the product’s labeli…
-
FDA approval · 2007-09-12FDA Approved: FLUTICASONE PROPIONATE — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for Fluticasone Propionate, submitted by Golden State Medical Supply, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-07-02FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for XOLAIR (omalizumab) from Genentech, Inc., to modify/expand its labeling.
-
FDA approval · 2007-06-26FDA Approved: ALBUTEROL SULFATE — Original Application (Chartwell RX, LLC)
FDA approved a generic albuterol sulfate product under an Original Application for Chartwell RX, LLC.
-
FDA approval · 2007-06-21FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for PULMICORT FLEXHALER (budesonide) by H2-Pharma LLC.
-
FDA approval · 2007-06-18FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Pulmicort Respules (budesonide) submitted by AstraZeneca Pharmaceuticals LP. The action pertains…
-
FDA approval · 2007-05-22FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for ipratropium bromide.
-
FDA approval · 2007-05-11FDA Approved: FORMOTEROL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for Formoterol Fumarate Dihydrate (FORMOTEROL FUMARATE) by Mylan Pharmaceuticals Inc., a long-acting b…
-
FDA approval · 2007-04-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2007-03-29FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for albuterol sulfate from Chartwell RX, LLC., updating an existing generic product.
-
FDA approval · 2007-03-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for albuterol sulfate from Nephron Pharmaceuticals Corporation under an abbreviated new drug applica…
-
FDA approval · 2007-02-23FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2007-02-23FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) filed by GlaxoSmithKline LLC.
-
FDA approval · 2007-02-16FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
FDA approval · 2006-12-28FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for EPINEPHRINE from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2006-12-08FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC.
-
FDA approval · 2006-11-20FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Pulmicort Respu les (budesonide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2006-10-25FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate HFA submitted by Prasco Laboratories under NDA 021433.
-
FDA approval · 2006-09-15FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate). The approval relates to changes descri…
-
FDA approval · 2006-07-21FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved the original application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP, a co…
-
FDA approval · 2006-07-21FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Pulmicort Respules (budesonide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2006-07-12FDA Approved: PULMICORT FLEXHALER — Original Application (H2-Pharma LLC)
FDA approved Pulmicort Flexhaler (budesonide) through an Original Application (NDA021949) by H2-Pharma LLC.